Your search returned 3 results.

Results
	1.	Phase I-II RTOG study (99-06) of patients with muscle-invasive bladder cancer undergoing transurethral surgery, paclitaxel, cisplatin, and twice-daily radiotherapy followed by selective bladder preservation or radical cystectomy and adjuvant chemotherapy. [electronic resource] by Kaufman, Donald S Winter, Kathryn A Shipley, William U Heney, Niall M Wallace, H James Toonkel, Leonard M Zietman, Anthony L Tanguay, Simon Sandler, Howard M Producer: 20090505 In: Urology vol. 73 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Long-Term Cancer Outcomes From Study NRG Oncology/RTOG 9517: A Phase 2 Study of Accelerated Partial Breast Irradiation With Multicatheter Brachytherapy After Lumpectomy for Early-Stage Breast Cancer. [electronic resource] by White, Julia Winter, Kathryn Kuske, Robert R Bolton, John S Arthur, Douglas W Scroggins, Troy Rabinovitch, Rachel A Kelly, Tracy Toonkel, Leonard M Vicini, Frank A McCormick, Beryl Producer: 20170703 In: International journal of radiation oncology, biology, physics vol. 95 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	RTOG 97-06: initial report of a phase I-II trial of selective bladder conservation using TURBT, twice-daily accelerated irradiation sensitized with cisplatin, and adjuvant MCV combination chemotherapy. [electronic resource] by Hagan, Michael P Winter, Kathryn A Kaufman, Donald S Wajsman, Zev Zietman, Anthony L Heney, Naill M Toonkel, Leonard M Jones, Christopher U Roberts, John D Shipley, William U Producer: 20031121 In: International journal of radiation oncology, biology, physics vol. 57 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)